Hydroxyzine Pamoate
Product Images NDC 10544-556

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydroxyzine Pamoate (NDC 10544-556). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

25mg 20ct (Label Hydroxyzine Pamoate Caps 25mg Bpi(10544 556 20) Watson(0591 0800 05) Rev1)

25mg 20ct (Label Hydroxyzine Pamoate Caps 25mg Bpi(10544 556 20) Watson(0591 0800 05) Rev1)
Hydroxyzine Pamoate Capsules, USP 25mg, is a medication available in a pack of 20 capsules. The NDC number is 1054455620, and the lot number is BPOOSDOOO with an expiry date of 0000000. The capsules contain Hydroxyzine Pamoate and have a USP equivalent to Hyroehlond Prarmacal. The recommended dosage information is provided in the package insert. The medication should be stored below 86°F (30°C) in a light-resistant container as per USP guidelines, and it must be kept out of reach of children. The text seems to contain several errors, which makes it difficult to comprehend in some places.*
FDA Label Image

Structure (Hydroxyzine Pamoate Capsules 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.